70
Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Embed Size (px)

Citation preview

Page 1: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Hypertension Guidelines 2015Barry D. Bertolet, MD

Cardiology Associates of North Mississippi

Tupelo – Columbus – Starkville - Oxford

Page 3: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Hypertension

• Hypertension is the most common condition in primary care.

• 68 million Americans > 18 years old (31%) have hypertension – that’s 1:3

• Incidence increases with age

• Risk factor for MI, CVA, ARF, death

Page 4: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

HTN Increases with Age

Page 5: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Progression to HTN Increases with Age

Page 6: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Hypertension Prevalence and Control in US Adults (%)

Page 7: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

2098 Franklin #7

BP and Ischemic Heart Disease Mortality

160 180140

Usual SBP (mm Hg)

90 100 110

IHD

Mo

rtal

ity

(Flo

atin

g A

bso

lute

Ris

k an

d 9

5% C

I)

1200

4

32

256

70 80

Usual DBP (mm Hg)

50-59

60-69

70-79

80-89

40-49

Age at Risk (y)

50-59

60-69

70-79

80-89

40-49

Age at Risk (y)

0

4

32

256

Adapted from Prospective Studies Collaboration. Lancet. 2002;360:1903-1913.

Page 8: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

2098 Franklin #8

CV Mortality Risk Doubles withEach 20/10 mm Hg BP Increment*

*Individuals aged 40-70 years, starting at BP 115/75 mm Hg.CV, cardiovascular; SBP, systolic blood pressure; DBP, diastolic blood pressureLewington S, et al. Lancet. 2002; 60:1903-1913. JNC 7. JAMA. 2003;289:2560-2572.

CVmortalityrisk

SBP/DBP (mm Hg)

0

1

2

3

4

5

6

7

8

115/75 135/85 155/95 175/105

Page 9: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Additive Effects

Page 10: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Benefits of Anti-hypertensive Tx

Page 11: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Benefits of Anti-Hypertensive Tx

Page 12: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

How Well Do We Do?

Page 13: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Barriers to Success

• Asymptomatic (silent killer)

• Non-compliance

• Therapeutic inertia– Not knowing the definition– Not knowing the goals– Not knowing the meds– Accepting less than ideal reductions

Page 14: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case

• A 58 year old African-American woman with diabetes and dyslipidemia has a BP of 158/94 confirmed on several office visits. Other than obesity, the exam is normal. Labs show normal renal function, well-controlled lipids on atorvastatin and well-controlled diabetes on metformin. Urine micro-albumin is mildly elevated.

Page 15: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 1

• What goal BP is most appropriate for this patient?

1. <150/90 mmHg

2. <130/80 mmHg

3. <140/90 mmHg

4. <140/80 mmHg

5. <140/85 mmHg

Page 16: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 2

• What is the drug of choice to start?

1. HCTZ

2. Norvasc

3. Lisinopril

4. Losartan

5. Bystolic

6. Combination therapy

Page 17: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC -7 Blood Pressure Guidelines

Page 18: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC-7 Treatment Algorithm

Page 19: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC-7 Compelling Indications

Page 20: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Development of JNC-8

• 3 critical questions for adults with hypertension– Does initiating antihypertensive pharmacologic

therapy at specific blood pressure thresholds improve health outcomes? [When to start therapy?]

– Does treatment with antihypertensive pharmacologic therapy to a specified blood pressure goal lead to improvements in health outcomes? [How low should I go?]

– Do various antihypertensive drugs or drug classes differ in comparative benefits and harms on specific health outcomes? [What drug do I use?]

Page 21: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC 8

• 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults– JAMA. 2014;311(5):507-520– December 18, 2013

Page 22: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC 8: Hypertension ManagementEvidence Review

• Limited to RCT’s– Hypertensive adults > 18 years old– Sample size > 100– Follow-up > 1 year– Reported effect of treatment on important

health outcomes (mortality, MI, HF, CVA, ESRD)

• January 1966 to December 2009– Separate criteria used of RCT’s published

after December 2009

Page 23: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC 8: Hypertension ManagementEvidence Review

• RCT’s December 2009 – August 20131. Major study in hypertension

• ACCORD, NEJM 2010

2. > 2,000 participants

3. Multicentered

4. Met all other inclusion/exclusion criteria

Page 24: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

What is the goal BP?

Page 25: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC 8: Drug TreatmentThresholds and Goals

• Age > 60 yo– Systolic:

• Threshold > 150 mmHg• Goal < 150 mmHg

– LOE: Grade A

– Diastolic:• Threshold > 90 mmHg• Goal < 90 mmHg

– LOE: Grade A

Page 26: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC 8: Drug TreatmentThresholds and Goals

• Age < 60 yo– Systolic:

• Threshold > 140 mmHg• Goal < 140 mmHg

– LOE: Grade E

– Diastolic:• Threshold > 90 mmHg• Goal < 90 mmHg

– LOE: Grade A for ages 40-59; Grade E for ages 18-39

Page 27: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC 8: Drug TreatmentThresholds and Goals

• Age > 18 yo with CKD or DM– JNC 7: < 130/80 (MDRD NEJM 1994)– Systolic:

• Threshold > 140 mmHg

• Goal < 140 mmHg– LOE: Grade E

– Diastolic:• Threshold > 90 mmHg

• Goal < 90 mmHg– LOE: Grade E

Page 28: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Initial Treatment Considerations

• Set blood pressure goal based on age, diabetes, and chronic kidney disease (CKD)

Page 29: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

What Are Effective Lifestyle Modifications for HTN?

• Weight Reduction

• DASH diet

• Dietary sodium reduction

• Physical Activity

• Decrease alcohol consumption

Page 30: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Hypertension

Page 31: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Select a Drug Titration Pathway

• CKD – all races– Initiate ACEI or ARB, alone or in

combination with other drug clsses

• Non CKD – black (Hispanic)– Initiate thiazide-type diuretic or CCB, alone

or in combination

• Non CKD – nonblack– Initiate thiazide-type diuretic or ACEI/ARB

or CCB, alone or in combination

Page 32: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford
Page 33: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

JNC 8: Subsequent Management

• Reassess treatment monthly

• Avoid ACEI/ARB combination

• Consider 2-drug initial therapy for Stage 2 HTN (> 160/100)

• Goal BP not reached with 3 drugs, use drugs from other classes– Consider referral to HTN specialist

Page 34: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

A Word about ACE-I / ARB Combinations It is Dead!

• Based on the results of the Renal Outcomes With Telmisartan, Ramipril, or Both, in People at High Vascular Risk (ONTARGET) study, the ARB telmisartan to be noninferior to the ACE inhibitor ramipril but the combination of the two together to be associated with more adverse events and no increased benefit.

• A separate, prespecified analysis looking at renal outcomes in ONTARGET showed that the ARB/ACE-inhibitor combination was associated with an increased risk of dialysis, doubling of serum creatinine, and death, compared with using either agent alone.

34

Page 35: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Subsequent Therapies

Black Non-Black

Step One Thiazide &/or Thiazide &/or

CCB ACE / ARB &/or

CCB

Step Two Add ACE / ARB Use combo

Step Three Add beta-blocker &/or Add beta-blocker &/or

aldactone aldactone

Step Four Others Others

Reinforce compliance and lifestyle modifications!

Page 36: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Dissenting Editorial

• Ann Intern Med. January 14, 2014

• 5/17 authors (29%)

• “Insufficient evidence” to increase target SBP to 150 mmHg.

• Expertise vs. Scientific Evidence

Page 37: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Recent HTN Guideline Statements

• 2013 ESH/ESC Guidelines for the management of arterial hypertension.

• J Hypertnsion 2013;31:1281-1357.

• An Effective Approach to High Blood Pressure Control: A Science Advisory From the AHA, ACC, and CDC.

• Hypertension online November 15, 2013.

• Clinical Practice Guidelines for the Management of HTN in the Community A Statements by the ASH/ISH.

• J Hypertension 2014;32:3-15

Page 38: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

What to do?

Page 39: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Comparison of RecentGuideline Statements

JNC 8 ESH/ESC AHA/ACC ASH/ISH

>140/90

Threshold >140/90 < 60 yr Eldery SBP >160 >140/90 <80 yr

for Drug Rx >150/90 >60 yr Consider SBP >140/90 >150/90 >80 yr140-150 if <80 yr

B-blocker No Yes No NoFirst line Rx

Initiate Therapy >160/100 "Markedly >160/100 >160/100w/ 2 drugs elevated BP"

Page 40: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Goal BP

Group BP Goal (mm Hg)General DM* CKD**

JNC 8: <60 yr: <140/90 < 140/90 < 140/90>60 yr: <150/90

ESH/ESC: < 140/90 < 140/85 < 140/90

Elderly 140-150/90 (SBP < 130 if proteinuria)

(<80 yr: SBP<140)

ASH/ISH < 140/90 < 140/90 < 140/90

>80 yr: <150/90 (Consider < 130/80 if proteinuria)

AHA/ACC < 140/90 < 140/90 < 140/90

*ADA: < 140/80 or lower**KDIGO: <140/90 w/o albuminuria

<130/80 if >30 mg/24hr

Page 41: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

BP goal in the elderly

Page 42: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Medical Education & Information – for all Media, all Disciplines, from all over the World Powered by

2013 ESH/ESC Guidelines for the management of arterial hypertension

The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) - J Hypertension 2013;31:1281-1357

Blood pressure goals in hypertensive patients

SBP, systolic blood pressure; CV, cardiovascular; TIA, transient ischaemic attack; CHD, coronary heart disease; CKD, chronic kidney disease;DBP, diastolic blood pressure.

Recommendations

SBP goal for “most”•Patients at low–moderate CV risk•Patients with diabetes•Consider with previous stroke or TIA•Consider with CHD•Consider with diabetic or non-diabetic CKD

<140 mmHg

SBP goal for elderly•Ages <80 years•Initial SBP ≥160 mmHg

140-150 mmHg

SBP goal for fit elderlyAged <80 years

<140 mmHg

SBP goal for elderly >80 years with SBP•≥160 mmHg

140-150 mmHg

DBP goal for “most” <90 mmHg

DB goal for patients with diabetes <85 mmHg

Page 43: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Reinforce Lifestyle Changes!

Page 44: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case

• A 58 year old African-American woman with diabetes and dyslipidemia has a BP of 158/94 confirmed on several office visits. Other than obesity, the exam is normal. Labs show normal renal function, well-controlled lipids on atorvastatin and well-controlled diabetes on metformin. Urine micro-albumin is mildly elevated.

Page 45: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case

• A 58 year old African-American woman with diabetes and dyslipidemia has a BP of 158/94 confirmed on several office visits. Other than obesity, the exam is normal. Labs show normal renal function, well-controlled lipids on atorvastatin and well-controlled diabetes on metformin. Urine micro-albumin is mildly elevated.

Page 46: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 1

• What goal BP is most appropriate for this patient?

1. <150/90 mmHg

2. <130/80 mmHg

3. <140/90 mmHg

4. <140/80 mmHg

5. <140/85 mmHg

Page 47: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 1

• What goal BP is most appropriate for this patient?

1. <150/90 mmHg

2. <130/80 mmHg

3. <140/90 mmHg

4. <140/80 mmHg

5. <140/85 mmHg

Page 48: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Initial Treatment Considerations

• Set blood pressure goal based on age, diabetes, and chronic kidney disease (CKD)

Page 49: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 2

• What is the drug of choice to start?

1. HCTZ

2. Norvasc

3. Lisinopril

4. Losartan

5. Bystolic

6. Combination therapy

Page 50: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 2

• What is the drug of choice to start?

1. HCTZ

2. Norvasc

3. Lisinopril

4. Losartan

5. Bystolic

6. Combination therapy

Page 51: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford
Page 52: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 3

• Despite amlodipine 5 mg and HCTZ 25 mg daily, she has a BP of 145/87. What is the next drug of choice to start?1. HCTZ

2. Norvasc

3. Lisinopril

4. Losartan

5. Bystolic

6. Combination therapy

Page 53: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 3

• Despite amlodipine 5 mg and HCTZ 25 mg daily, she has a BP of 145/87. What is the next drug of choice to start?1. HCTZ

2. Norvasc

3. Lisinopril

4. Losartan

5. Bystolic

6. Combination therapy

Page 54: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Subsequent Therapies

Black Non-Black

Step One Thiazide &/or Thiazide &/or

CCB ACE / ARB &/or

CCB

Step Two Add ACE / ARB Use combo

Step Three Add beta-blocker &/or Add beta-blocker &/or

aldactone aldactone

Step Four Others Others

Reinforce compliance and lifestyle modifications!

Page 55: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Physiological Effects of DiureticsPhysiological Effects of Diuretics

Diuretics

↓ Plasma volume

↓ Cardiac Output

Initially

Long-term

Counter-regulatoryMechanisms

↓ Blood Pressure

↓ Arterial Resistance

↓ Renal Perfusion

↑ Renin/Angiotensin Activity

↑ Arterial Resistance

↑ Blood Pressure

Adapted from Moser and Setaro, Med Clin N Am 2004;88:167-187.

Page 56: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

True or False

• 65 year old “healthy” man presents for evaluation. Serial BPs show an average of 148/88 with no improvement after a 3 month period of diet and exercise. There is no history of CAD, diabetes, or renal disease.

• Based on the new HTN guidelines, medical therapy should be initiated.

Page 57: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

True or False

• 65 year old “healthy” man presents for evaluation. Serial BPs show an average of 148/88 with no improvement after a 3 month period of diet and exercise. There is no history of CAD, diabetes, or renal disease.

• Based on the new HTN guidelines, medical therapy should be initiated.

False

Page 58: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Initial Treatment Considerations

• Set blood pressure goal based on age, diabetes, and chronic kidney disease (CKD)

Page 59: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case

• A 78 year old Caucasian man with history of CABG is seen with a BP of 160/104 and confirmed this range on several office visits.

• He has been placed on a DASH diet for three months.

• Other than mild dementia, the exam is normal. Lab is remarkable for a Cr 2.4 and LDL 120 mg/dl.

Page 60: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 1

• What goal BP is most appropriate for this patient?

1. <150/90 mmHg

2. <130/80 mmHg

3. <140/90 mmHg

4. <140/80 mmHg

5. <140/85 mmHg

Page 61: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 1

• What goal BP is most appropriate for this patient?

1. <150/90 mmHg

2. <130/80 mmHg

3. <140/90 mmHg

4. <140/80 mmHg

5. <140/85 mmHg

Page 62: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case

• A 78 year old Caucasian man with history of CABG is seen with a BP of 160/104 and confirmed this range on several office visits.

• He has been placed on a DASH diet for three months.

• Other than mild dementia, the exam is normal. Lab is remarkable for a Cr 2.4 and LDL 120 mg/dl.

Page 63: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Initial Treatment Considerations

• Set blood pressure goal based on age, diabetes, and chronic kidney disease (CKD)

Page 64: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 2

• Appropriate initial (and minimum) therapy would include:1. Aspirin, ACEI, beta-blocker, and

atorvastatin 10 mg

2. Aspirin, ACEI, thiazide, and pravastatin 20 mg

3. Aspirin, ACEI, and atorvastatin 40 mg

4. Aspirin and ACEI

Page 65: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 2

• Appropriate initial (and minimum) therapy would include:1. Aspirin, ACEI, beta-blocker, and

atorvastatin 10 mg

2. Aspirin, ACEI, thiazide, and pravastatin 20 mg

3. Aspirin, ACEI, and atorvastatin 40 mg

4. Aspirin and ACEI

Page 66: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford
Page 67: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford
Page 68: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Intensity of Statin Therapy

Page 69: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Case Question 2

• Appropriate initial (and minimum) therapy would include:1. Aspirin, ACEI, beta-blocker, and

atorvastatin 10 mg

2. Aspirin, ACEI, thiazide, and pravastatin 20 mg

3. Aspirin, ACEI, and atorvastatin 40 mg

4. Aspirin and ACEI

Page 70: Hypertension Guidelines 2015 Barry D. Bertolet, MD Cardiology Associates of North Mississippi Tupelo – Columbus – Starkville - Oxford

Thank you for your attention!